Oncology startup Oncare has secured ₹27 Cr (approximately $3 Mn) in a Series A funding round to bolster its efforts in expanding its network of cancer care clinics. Led by Sky Impact Capital, the funding round also saw contributions from Huddle Ventures, Lotus Herbal Group, SteerX, and Tremis Capital. The startup’s primary focus with the new capital infusion is to broaden its presence in various metro cities and Tier-2 and Tier-3 markets across India. Additionally, Oncare aims to invest in technology solutions to enhance its clinical operations, care coordination, and overall patient experience.
Founded in 2023 by Amar Sneh and Deepak Kumar, Oncare operates a distributed oncology care model that emphasizes partnering with accredited hospitals to provide comprehensive medical, surgical, and radiation oncology services under one unified platform. Currently operating multiple centers in the Delhi NCR region, the startup is strategically positioning itself to establish a nationwide network dedicated to standardized and transparent cancer care.
The infusion of funds into Oncare aligns with the burgeoning growth of the Indian oncology market, which is expected to reach ₹43,000 Cr by FY28, growing at a rate of approximately 14% CAGR. This investment underscores a broader trend where investors are increasingly supporting specialized care models that target specific healthcare needs effectively.
The healthcare technology sector in India is witnessing substantial growth, with the overall healthtech market projected to achieve a 39% CAGR between 2025 and 2030, surpassing $37 Bn. Notably, Indian healthtech startups raised nearly $700 Mn in 2025, signifying sustained investor interest in innovative healthcare solutions.
Source: Inc42 Media